FDA considers doctor-like ‘competency-based’ tests for medical generative AI

The FDA’s move to implement competency-based testing represents a critical shift toward rigorous safety standards for generative AI in clinical settings. By treating algorithms like medical professionals, regulators are ensuring that automated diagnostic tools meet strict performance benchmarks before entering the healthcare ecosystem.